Burstable Editorial Team
NewsRamp Burstable Feed
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
24568 articles
Articles
SureNano Science’s GLP-1 Triple Agonist Peptide GEP-44 Highlights Next-Generation Innovation in Metabolic Disease Treatment
SureNano Science Ltd., through its subsidiary GlucaPharm Inc., is advancing GEP-44, a novel triple agonist peptide with potential for enhanced efficacy and non-injectable delivery in the growing GLP-1 therapeutic market for obesity and type 2 diabetes.
May 14, 2026Read the full article
BluSky AI Launches Regulation A+ Offering for AI Infrastructure Expansion
BluSky AI Inc. has initiated a Regulation A+ offering to raise funds for expanding its distributed AI infrastructure network, allowing individual and accredited investors to participate with a minimum investment of $1,000.
May 14, 2026Read the full article
American Fusion Inc. Highlights Strategic Washington Engagements and Corporate Progress
American Fusion Inc. updates on D.C. meetings for defense and energy applications, Form 10 filing, and OTCQB pursuit, advancing its Texatron fusion platform toward commercialization.
May 14, 2026Read the full article
NextPlat Corp Reports Improved First-Quarter 2026 Results as Turnaround Initiatives Gain Traction
NextPlat Corp announced improved first-quarter 2026 operating results, including a record gross margin of 35% and a 42% reduction in net loss, driven by ongoing turnaround efforts despite lower year-over-year revenue.
May 14, 2026Read the full article
Aditxt Announces 1-for-27 Reverse Stock Split to Regain Nasdaq Compliance
Aditxt Inc. will implement a 1-for-27 reverse stock split effective May 18, 2026, to meet Nasdaq's minimum bid price requirement, reducing outstanding shares from approximately 13.8 million to about 510,123.
May 14, 2026Read the full article
Oncotelic Therapeutics Featured in BioMedWire Editorial Highlighting Nose-to-Brain Drug Delivery for Alzheimer's and Biodefense
Oncotelic Therapeutics' proprietary intranasal nose-to-brain delivery platform, featured in a BioMedWire editorial, offers a novel approach to bypass the blood-brain barrier for treating neurological diseases like Alzheimer's and advancing biodefense research.
May 14, 2026Read the full article
SPARC AI's GPS-Denied Navigation Platform Featured in Editorial on Autonomous Warfare
SPARC AI Inc. has been highlighted in an AINewsWire editorial for its software-only platform that enables drones to navigate and target precisely without GPS, addressing critical defense needs in contested electronic warfare environments.
May 14, 2026Read the full article
Duck Key's Dining Scene Enhances Luxury Real Estate Appeal, Says Top Selling Team
The Brenner Scheel & Casey Team highlights that the diverse and high-quality dining options in the Middle Keys are a key factor for luxury homebuyers evaluating waterfront estates on Duck Key.
May 14, 2026Read the full article
Crypto Asset Products See Sixth Week of Inflows Amid U.S. Regulatory Optimism
Crypto investment products attracted nearly $860 million in fresh capital last week, marking six consecutive weeks of positive flows, driven by optimism over proposed U.S. regulation.
May 14, 2026Read the full article
HHS Proposal to Ease AI Healthcare Safeguards Draws Mixed Reactions
The Department of Health and Human Services plans to relax safeguards for AI healthcare tools, sparking debate over the need for real-world testing and regulation.
May 14, 2026Read the full article
Alphabet Plans Yen-Denominated Bonds to Finance AI Investments
Alphabet is issuing yen-denominated bonds to fund its AI ambitions, reflecting a trend among tech giants to tap overseas debt markets for AI-related costs.
May 14, 2026Read the full article
China to Regulate EV Battery Recycling, Targeting Informal Market Capture
China is implementing new regulations to formalize electric vehicle battery recycling, aiming to curb safety and environmental risks from informal operations that currently handle about 70% of retired batteries.
May 14, 2026Read the full article
Microsoft May Delay or Abandon Clean Energy Goals Amid Surging AI Power Demand
Microsoft is considering scaling back its ambitious 2030 clean energy goal due to rising power demands from AI data centers, highlighting a tension between tech growth and climate commitments.
May 14, 2026Read the full article
MindBio Therapeutics Featured in BioMedWire Editorial on Real-Time Intoxication Detection via AI Voice Analysis
MindBio Therapeutics Corp. is highlighted in a BioMedWire editorial for its AI-driven voice analysis platform that detects drug and alcohol intoxication, with potential applications in healthcare, workplace safety, and public health.
May 14, 2026Read the full article
Study Links Low Testosterone to Shorter Survival in Men with Glioblastoma
New NIH-funded research shows that low testosterone levels in men are associated with shorter survival times in glioblastoma, potentially influencing treatment approaches.
May 14, 2026Read the full article
Strait of Hormuz Disruption Threatens EV Battery Supply Chains and Manufacturing
The ongoing crisis in the Strait of Hormuz is endangering the global electric vehicle industry by disrupting the transport of critical raw materials for battery production, potentially leading to supply shortages, higher costs, and production slowdowns.
May 14, 2026Read the full article
SureNano Science Featured in BioMedWire Editorial Highlighting Next-Generation GLP-1 Innovation
SureNano Science Ltd. and its subsidiary GlucaPharm Inc. are spotlighted in a BioMedWire editorial for developing GEP-44, a novel triple agonist peptide aimed at improving obesity and type 2 diabetes treatment with enhanced tolerability and delivery options.
May 14, 2026Read the full article
CNS Pharmaceuticals Reports First-Quarter 2026 Results, Advances Strategic Transformation Toward Acquisition-Driven Growth
CNS Pharmaceuticals reported Q1 2026 results and progress on its shift to an acquisition-driven model in neurology and oncology, supported by a $22.5M private placement to fund operations beyond 12 months.
May 14, 2026Read the full article
BluSky AI Advances Modular Data Center Strategy to Meet Surging AI Infrastructure Demand
BluSky AI Inc. is accelerating its SkyMod modular data center deployment to address the critical shortage of high-performance computing infrastructure driven by rising AI demand.
May 14, 2026Read the full article
Trilogy Metals Shareholders Approve All Proposals at Annual Meeting
Trilogy Metals Inc. announced that shareholders approved all proposals at its annual meeting, including the election of directors and advisory vote on executive compensation, with 62.84% of eligible shares represented.
May 14, 2026Read the full article
Kairos Pharma Wins 2026 Healthcare Innovation Award for Drug Resistance Research
Kairos Pharma has been honored with the 2026 GHP Magazine Healthcare & Pharmaceutical Award for its leadership in drug resistance development, highlighting its work on therapies to overcome cancer treatment resistance.
May 14, 2026Read the full article